Mark E. Hatley
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
-
- Sarcoma Diagnosis and Treatment 12
- Co-authors
- Matthew R. Garcia (8 shared papers)Eric N. Olson (2 shared papers)Eva van Rooij (2 shared papers)James A. Richardson (1 shared paper)David M. Patrick (1 shared paper)Rhonda Bassel‐Duby (1 shared paper)Rene L. Galindo (2 shared papers)DAVID B. FINKELSTEIN (7 shared papers)
- Journals
- Cancer Cell (4 papers)Nature Communications (3 papers)Pediatric Blood & Cancer (2 papers)Cancer Research (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- United StatesUnited KingdomNew Zealand
In The Last Decade
Mark E. Hatley
23 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 663
- Pulmonary and Respiratory Medicine 494
- Molecular Biology 1.1k
- Oncology 230
- Pathology and Forensic Medicine 108
Countries citing papers authored by Mark E. Hatley
This map shows the geographic impact of Mark E. Hatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Hatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Hatley more than expected).
Fields of papers citing papers by Mark E. Hatley
This network shows the impact of papers produced by Mark E. Hatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Hatley. The network helps show where Mark E. Hatley may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Hatley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 556 | |
| 2 | 2013 | 233 | |
| 3 | 2003 | 112 | |
| 4 | 2012 | 106 | |
| 5 | 2015 | 103 | |
| 6 | 2014 | 85 | |
| 7 | 2015 | 68 | |
| 8 | 2018 | 66 | |
| 9 | 2019 | 57 | |
| 10 | 2018 | 40 | |
| 11 | 2022 | 33 | |
| 12 | 2016 | 30 | |
| 13 | 2023 | 18 | |
| 14 | 2017 | 17 | |
| 15 | 2023 | 17 | |
| 16 | 2021 | 16 | |
| 17 | 2000 | 15 | |
| 18 | 1995 | 10 | |
| 19 | 2024 | 9 | |
| 20 | 2022 | 7 |
About Mark E. Hatley
Mark E. Hatley is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Hematology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (12 papers), Cancer-related molecular mechanisms research (5 papers), CAR-T cell therapy research (3 papers), Circular RNAs in diseases (3 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Cardiac tumors and thrombi (2 papers). The work is most often cited by research in Cancer Research (663 citations), Pulmonary and Respiratory Medicine (494 citations), Molecular Biology (1.1k citations), Oncology (230 citations) and Pathology and Forensic Medicine (108 citations). Mark E. Hatley has collaborated with scholars based in United States, United Kingdom and New Zealand. Frequent co-authors include Matthew R. Garcia, Eric N. Olson, Eva van Rooij, James A. Richardson, David M. Patrick, Rhonda Bassel‐Duby, Rene L. Galindo, DAVID B. FINKELSTEIN, Alfred G. Gilman and Rama Ranganathan. Their work appears in journals such as Cancer Cell, Nature Communications, Pediatric Blood & Cancer, Cancer Research and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.